Lack of association between right-to-left shunt and cerebral ischemia after adjustment for gender and age.

Department of Neurology, Klinikum Rechts der Isar, Technische Universitaet Muenchen, Ismaningerstr. 22, 81675 Muenchen, Germany.
Journal of Negative Results in BioMedicine (Impact Factor: 1.47). 10/2008; 7:7. DOI: 10.1186/1477-5751-7-7
Source: PubMed

ABSTRACT A number of studies has addressed the possible association between patent foramen ovale (PFO) and stroke. However, the role of PFO in the pathogenesis of cerebral ischemia has remained controversial and most studies did not analyze patient subgroups stratified for gender, age and origin of stroke.
To address the role of PFO for the occurrence of cerebral ischemia, we investigated the prevalence of right-to-left shunt in a large group of patients with acute stroke or TIA. 763 consecutive patients admitted to our hospital with cerebral ischemia were analyzed. All patients were screened for the presence of PFO by contrast-enhanced transcranial Doppler sonography at rest and during Valsalva maneuver. Subgroup analyses were performed in patients stratified for gender, age and origin of stroke.
A right-to-left shunt was detected in 140 (28%) male and in 114 (42%) female patients during Valsalva maneuver, and in 66 (13%) and 44 (16%) at rest respectively. Patients with right-to-left shunt were younger than those without (P < 0.001). PFO was associated with stroke of unknown origin in male (P = 0.001) but not female patients (P > 0.05). After adjusting for age no significant association between PFO and stroke of unknown origin was found in either group.
Our findings argue against paradoxical embolization as a major cause of cerebral ischemia in patients with right-to-left shunt. Our data demonstrate substantial gender-and age-related differences that should be taken into account in future studies.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Ischemic stroke in younger people is common, and often remains unexplained. There is a well-documented association between unexplained stroke in younger people, and the presence of a patent foramen ovale. Therefore, in the absence of a clear cause of stroke, the heart is often assessed in detail for such lower risk causes of stroke. This usually involves imaging with a transesophageal echo, and investigation for a right-to-left shunt. An understanding of the anatomy of the atrial septum, and its associated abnormalities, is important for the stroke neurologist charged with decision making regarding appropriate secondary prevention. In this paper, we review the development and anatomy of the right heart with a focus on patent foramen ovale, and other associated abnormalities. We discuss how the heart can be imaged in the case of unexplained stroke, and provide examples. Finally, we suggest a method of investigation, in light of the recent European Association of Echocardiography guidance. Our aim is to provide the neurologist with an understanding on how the heart can be investigated in unexplained stroke, and the significance of abnormalities detected.
    International Journal of Stroke 10/2011; 6(5):445-53. · 4.03 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Rationale Patent foramen ovale (PFO) may be disadvantageous in COPD. It is unknown whether right to left shunting through PFO increases during exercise impairing exercise performance. Objectives To determine whether: 1) PFO prevalence is greater in hypoxemic versus less hypoxemic COPD patients, 2) PFO is associated with clinically relevant impairment, and 3) right to left shunting increases during exercise and impairs exercise performance. Methods COPD patients and age-matched controls underwent contrast transthoracic echocardiography and transcranial Doppler to identify PFO. COPD patients with no shunt and patients with large PFO underwent cardiopulmonary exercise tests with contrast transcranial Doppler, esophageal and gastric balloon catheters. Measurements and main results PFO prevalence was similar in 50 COPD and 50 healthy controls 46% versus 30%, p=0.15. Large shunts were more common in COPD patients: 26% versus 6%, p=0.01. In an expanded COPD cohort, PFO prevalence was similar in 31 hypoxemic (PaO2 ≤7.3 kPa) and 63 less hypoxemic (PaO2 >8.0 kPa) COPD patients: 39% versus 52%, p=0.27. Patients with intrapulmonary shunting had lower PaO2 than either patients with PFO and those with no right to left shunt (7.7kPa versus 8.6kPa versus 9.3kPa respectively, p=0.002). Shunting significantly increased during exercise in COPD patients with PFO. Endurance time at 60% VO2max was 574 (178)s for patients with PFO and 534 (279)s for those without p=ns. Conclusions Hypoxemic COPD patients do not have a higher prevalence of PFO. COPD patients with PFO do not perform less well either on a six minute walk or submaximal exercise testing despite increased right to left shunting during exercise.
    American Journal of Respiratory and Critical Care Medicine 01/2014; · 11.04 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A patent foramen ovale (PFO) is detectable in 20-25% of the population. Some, but not all, case control studies have found an increased incidence of PFO in patients with cryptogenic stroke. Prospective cohort studies have failed to convincingly demonstrate a link between PFO and first stroke, and evidence linking PFO to recurrent stroke is far from compelling. The rate of recurrent stroke in medically treated patients is low, but the development of devices for PFO closure has lead to enthusiasm in some quarters to pursue a strategy of device closure. Nonrandomized studies have suggested a lower risk of recurrent events with device closure but the data are heterogeneous, and potentially prone to bias. Device implantation is associated with a risk of major adverse events of between 1.5% and 2.3%, and there is a significant rate of failure to close shunts. The results of randomized trials of device closure are keenly awaited. Migraine with aura has been linked with PFO. A recent metanalysis suggested an association, but the one prospective population study did not. The well-publicized and controversial MIST Trial is the only randomized trial of device closure in migraineurs yet published, and failed to demonstrate a convincing benefit from device closure. Other conditions such as platypnea-orthodeoxia syndrome and prevention of decompression sickness in divers, may justify device closure. Evidence for a role of PFO in the etiology of cryptogenic stroke and migraine is contradictory. It is possible that some patients might benefit from PFO closure but there is scant evidence of sufficient quality to justify routine PFO closure in either group. It is essential that ongoing randomized trials of device closure are completed.
    Cardiovascular Therapeutics 02/2011; 30(3):e128-35. · 2.85 Impact Factor

Full-text (2 Sources)

Available from
May 23, 2014

Holger Poppert